---
title: "12 Health Care Stocks Moving In Monday's Intraday Session"
description: "In Monday's intraday session, Venus Concept (VERO) saw a significant gain of 297.2%, reaching $5.68, with a market cap of $2.6 million. Other notable gainers included INVO Fertility (IVF) up 200.06% t"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/272993919.md"
published_at: "2026-01-19T17:05:41.000Z"
---

# 12 Health Care Stocks Moving In Monday's Intraday Session

> In Monday's intraday session, Venus Concept (VERO) saw a significant gain of 297.2%, reaching $5.68, with a market cap of $2.6 million. Other notable gainers included INVO Fertility (IVF) up 200.06% to $2.44, and ImmunityBio (IBRX) rising 52.93% to $6.04. Conversely, PAVmed (PAVM) experienced the largest decline, down 28.1% to $6.29. Other losers included Inspire Veterinary (IVP) down 24.81% and Agape ATP (ATPC) down 23.72%.

### Gainers

-   **Venus Concept** (NASDAQ:VERO) shares moved upwards by 297.2% to $5.68 during Monday's regular session. The market value of their outstanding shares is at $2.6 million.
-   **INVO Fertility** (NASDAQ:IVF) shares increased by 200.06% to $2.44. The company's market cap stands at $12.2 million.
-   **ImmunityBio** (NASDAQ:IBRX) stock rose 52.93% to $6.04. The market value of their outstanding shares is at $3.8 billion.
-   **Jaguar Health** (NASDAQ:JAGX) stock increased by 41.26% to $1.08. The market value of their outstanding shares is at $3.1 million.
-   **Bristol-Myers Squibb Company Celegne Contingent Value Rights** (NYSE:CELGR) stock rose 34.55% to $0.21.
-   **PainReform** (NASDAQ:PRFX) shares moved upwards by 29.41% to $1.06. The market value of their outstanding shares is at $3.2 million.

### Losers

-   **PAVmed** (NASDAQ:PAVM) shares decreased by 28.1% to $6.29 during Monday's regular session. The market value of their outstanding shares is at $8.0 million.
-   **Inspire Veterinary** (NASDAQ:IVP) shares declined by 24.81% to $0.04. The market value of their outstanding shares is at $2.0 million.
-   **Agape ATP** (NASDAQ:ATPC) shares decreased by 23.72% to $0.08. The company's market cap stands at $5.4 million.
-   **Nuwellis** (NASDAQ:NUWE) stock declined by 21.52% to $1.86. The market value of their outstanding shares is at $2.1 million.
-   **Prelude Therapeutics** (NASDAQ:PRLD) stock fell 16.75% to $1.79. The market value of their outstanding shares is at $135.1 million.
-   **Gelteq** (NASDAQ:GELS) shares fell 15.33% to $1.05. The company's market cap stands at $13.2 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [IBB.US - iShares Biotechnology ETF](https://longbridge.com/en/quote/IBB.US.md)
- [BIB.US - Proshares Ultra Nasdaq Biotech](https://longbridge.com/en/quote/BIB.US.md)
- [ATPC.US - Agape ATP](https://longbridge.com/en/quote/ATPC.US.md)
- [XHS.US - SPDR S&P Health](https://longbridge.com/en/quote/XHS.US.md)
- [FBT.US - First Trust NYSE Arca Biotech Index Fd](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US - SPDR S&P Biotech](https://longbridge.com/en/quote/XBI.US.md)
- [IBRX.US - ImmunityBio](https://longbridge.com/en/quote/IBRX.US.md)
- [PBE.US - Invesco Biotechnology & Genome ETF](https://longbridge.com/en/quote/PBE.US.md)
- [VERO.US - Venus Concept](https://longbridge.com/en/quote/VERO.US.md)
- [IBBQ.US - Invesco Nasdaq Biotechnology ETF](https://longbridge.com/en/quote/IBBQ.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 期权热点｜周二 IBRX 大涨 17%，部分看涨期权飙升 128% | 美东时间 02 月 24 日，IBRX 期权总成交 149358 张，看涨期权占比 79%，看跌期权占比 20%。 | [Link](https://longbridge.com/en/news/276829867.md) |
| ImmunityBio 超越预期，实现收入五倍增长 | ImmunityBio Inc.（纳斯达克代码：IBRX）报告称，收入增长了五倍，主要得益于 Anktiva 销售激增 750%，达到 3829 万美元，超出预期。该公司已与合作伙伴达成协议，在沙特阿拉伯及中东和北非地区推出 Anktiva | [Link](https://longbridge.com/en/news/276923608.md) |
| PROCEPT BioRobotics 未能达到第四季度收入和调整后 EBITDA 的预期 | Procept Biorobotics 报告称，第四季度收入同比增长 12%，但未能达到分析师预期，实际收入为 7638 万美元，而共识为 9414 万美元。该公司还报告了 1900 万美元的调整后 EBITDA 亏损。尽管业绩不及预期，P | [Link](https://longbridge.com/en/news/276939780.md) |
| QT Imaging Holdings (QTI) 获得了 Lake Street 的买入评级 | Lake Street 分析师 Ben Haynor 对 QT Imaging Holdings (QTI) 维持了买入评级，目标价为 10.00 美元。Haynor 的平均回报率为 -12.3%，成功率为 30.05%，专注于医疗保健领域 | [Link](https://longbridge.com/en/news/276750599.md) |
| Neurent Medical 宣布 NEUROMARK®系统的随机对照试验结果呈积极 | Neurent Medical 宣布其 NEUROMARK® 系统在慢性鼻炎的随机对照试验中取得了积极结果。研究显示，该系统使用射频后鼻神经消融，与假控制组相比，显著改善了鼻部症状和生活质量。关键发现包括治疗组的应答率为 73.3%，而对照 | [Link](https://longbridge.com/en/news/276755975.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.